![]() |
市場調查報告書
商品編碼
1661631
神經血管血栓消除設備的全球市場的評估:各類型,各用途,各終端用戶,各地區,機會及預測,2018~2032年Global Neurovascular Thrombectomy Devices Market Assessment, By Type, By Application, By End User, By Geographies Opportunities, and Forecast, 2018-2032F |
全球神經血管血栓切除設備市場預計在 2024 年達到 29.5 億美元,預計在 2025-2032 年預測期內的複合年增長率為 6.72%。微創手術的興起、患者群體中中風發病率的增加、技術突破、報銷政策以及新興經濟體政府增加醫療保健支出是推動市場擴張的一些因素。預計中國和印度等亞太國家將在 2025 年至 2032 年間成為新的創收市場。
預計在預測期內,主要參與者的持續產品開發以及透過建立製造設施、研發設施和分銷網絡擴大在新興國家的影響力將推動血栓切除設備的進一步增長。根據世界衛生組織發布的報告,神經血管血栓切除術在已開發國家和新興國家均表現出改善術後患者預後的效果,血栓切除術在已開發國家和新興國家均呈現迅速發展。接受血栓切除術治療的大血管閉塞或 LVO 中風患者的比例因國家而異,但大多數情況下仍低於 15%。
全部的市場區隔,是變成對象的全部的地區和國家提供。
上述公司尚未根據市場佔有率保留訂單,並且可能根據研究工作期間可用的資訊而發生變化。
The Global Neurovascular Thrombectomy Devices Market was estimated at 2.95 billion in 2024, and is projected to grow at a CAGR of 6.72% for the forecast period between 2025 and 2032. Increasing number of minimally invasive procedures, increasing incidence of stroke in patient population, technological breakthroughs, reimbursement policies, and rising healthcare expenditure by governments across emerging economies are some of the factors driving market expansion. Asia-Pacific nations such as China and India are predicted to emerge as new revenue-generating markets between 2025 and 2032.
Ongoing product developments by leading companies and key market players expanding their presence in emerging countries through the establishment of manufacturing facilities, research and development facilities, and distribution networks are expected to drive further growth of thrombectomy devices during the forecast period. As per reports published by WHO, neurovascular thrombectomy have shown improved patient outcomes post-surgery in developed and emerging countries, thrombectomy operations have grown rapidly in both established and emerging countries. The percentage of large vessel occlusion or LVO stroke patients undergoing thrombectomy treatments varies by country, however most of them stay below 15%.
Mergers and Acquisitions Support Market Expansion
Mergers and acquisitions are significant a driver for the global neurovascular thrombectomy devices market. They enable companies to expand their product portfolios by acquiring advanced technologies, thus catering to a wider range of medical needs. Mergers and acquisitions also facilitate entry into new geographic markets, increasing patient reach, and thus market share. Additionally, combining resources through mergers and acquisitions enhances research and development capabilities, leading to the innovation of more effective thrombectomy devices. Strategic partnerships formed through mergers and acquisitions improve supply chain efficiency and distribution networks, bolstering overall operational effectiveness.
For instance, in January 2025, Stryker Corporation announced a definitive agreement to acquire Inari Medical, Inc. This acquisition is expected to enhance Stryker's capabilities in treating vascular diseases, particularly in the context of thrombectomy procedures. This strategic move is allowing Stryker to broaden its product portfolio and address a wider range of vascular conditions, enhancing its market presence.
Stent Retriever is Dominating the Global Neurovascular Thrombectomy Devices Market
In 2022, the stent retrievers accounted for majority share the overall mechanical thrombectomy devices market, owing to increased reimbursement, increased public-private investments in product development & commercialization, and increased patient emphasis on minimally invasive therapeutic procedures.
North America is Expected to Hold a Significant Share during the Forecast Period
Over the projected period, North America is likely to have a sizable market share. The increasing frequency of acute ischemic strokes, increased research and development, regular product launches, and rising strategic initiatives by leading market players are the fundamental driving drivers for the North American neurovascular thrombectomy devices market.
Due to high frequency of stroke in the United States, the North American is expected to hold a substantial proportion of the market over the study period. According to the Centers for Disease Control and Prevention (CDC) report published in April 2022, more than 795,000 people in the United States experience a stroke each year and ischemic strokes account for approximately 87% of all reported strokes.
Impact of COVID-19 on the Global Neurovascular Thrombectomy Devices Market
COVID-19 has had a significant impact on the healthcare industry, including the neurovascular thrombectomy devices market. On one hand, there has been an increase in demand for these devices due to the higher incidence of stroke in COVID-19 patients. COVID-19 is known to cause blood clotting, which can increase the risk of stroke in patients. On the other hand, the pandemic disrupted supply chain and led to manufacturing and distribution challenges for neurovascular thrombectomy device manufacturers. Some manufacturers had to delay or halt production due to workforce shortages, supply chain disruptions, and other factors. This led to a shortage of neurovascular thrombectomy devices in some regions, which affected patient's access to these devices.
Impact of Russia-Ukraine War on the Global Neurovascular Thrombectomy Devices Market
The war between Russia and Ukraine had an indirect negative impact on the neurovascular thrombectomy market on a global scale. Geopolitical tensions and conflicts can have broader impacts on the global economy and neurovascular thrombectomy market due to trade disruptions, supply chain interruptions and economic sanctions imposed by United States and European countries on Russia.
Key Players Landscape and Outlook
Some of the leading companies in the Neurovascular Thrombectomy Devices market are Johnson & Johnson Medical Ltd, Medtronic Plc, Wallaby Medical Inc, Terumo Corp, Stryker Corp, Imperative Care Inc, Penumbra Inc, Balt SAS, and Acandis GmbH & Co KG. Medtronic Plc.
All segments will be provided for all regions and countries covered
Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work